Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches

Abstract

Background: Pharmacological approaches are widely used for post-traumatic stress disorder (PTSD) despite uncertainty over efficacy. Objectives: To determine the efficacy of all pharmacological approaches, including monotherapy, augmentation and head-to-head approaches (drug versus drug, drug versus psychotherapy), in reducing PTSD symptom severity. Method: A systematic review and meta-analysis of randomised controlled trials were undertaken; 115 studies were included. Results: Selective serotonin reuptake inhibitors (SSRIs) were found to be statistically superior to placebo in reduction of PTSD symptoms but the effect size was small (standardised mean difference −0.28, 95% CI −0.39 to −0.17). For individual monotherapy agents compared to placebo in two or more studies, we found small statistically significant evidence for the antidepressants fluoxetine, paroxetine, sertraline, venlafaxine and the antipsychotic quetiapine. For pharmacological augmentation, we found small statistically significant evidence for prazosin and risperidone. Conclusions: Some medications have a small positive effect on reducing PTSD symptom severity and can be considered as potential monotherapy treatments; these include fluoxetine, paroxetine, sertraline, venlafaxine and quetiapine. Two medications, prazosin and risperidone, also have a small positive effect when used to augment pharmacological monotherapy. There was no evidence of superiority for one intervention over another in the small number of head-to-head comparison studies. Tratamiento farmacologico para el trastorno de estres postraumatico: una revision sistematica y metanalisis de monoterapia, potenciacion y abordajes comparativos Antecedentes: Los abordajes farmacológicos se usan ampliamente para el trastorno de estrés postraumático (TEPT) a pesar de su eficacia incierta. Objetivos: Determinar la eficacia de todos los abordajes farmacológicos, incluyendo monoterapia, potenciación y abordajes comparativos (droga versus droga, droga versus psicoterapia), en la reducción de la severidad de los síntomas de TEPT. Método: Se llevó a cabo una revisión sistemática y metanálisis de estudios controlados aleatorizados; se incluyeron 115 estudios. Resultados: Se encontró que los inhibidores selectivos de la recaptación de serotonina (ISRSs) fueron estadísticamente superiores a placebo en la reducción de los síntomas de TEPT, pero el tamaño de efecto fue pequeño (diferencia media estandarizada −0.28, IC 95% −0.39 a −0.17). Para agentes en monoterapia individuales comparados con placebo en dos o más estudios, encontramos para los antidepresivos fluoxetina, paroxetina, sertralina, venlafaxina y el antipsicótico quetiapina una evidencia estadísticamente significativa pequeña. Para la potenciación farmacológica, encontramos para prazosina y risperidona, evidencia estadísticamente significativa pequeña. Conclusiones: Algunos medicamentos tienen un efecto positivo pequeño en la reducción de la severidad de los síntomas de TEPT y pueden ser considerados como potenciales tratamientos en monoterap...

Prevention and treatment of PTSD: the current evidence base

“…Pharmacological treatment of adults with PTSD (Hoskins et al, 2020 ). This paper demonstrates strong low effect evidence for a number of pharmacological approaches.…”

Sexual assault as a public health problem and other developments in psychotraumatology

“…Another systematic review addressed the efficacy of early interventions (Roberts, Kitchiner, Kenardy, Lewis, & Bisson, 2019 ). Pharmacological treatment of PTSD (Hoskins, Bridges, et al, 2021 ) and pharmacologically assisted psychotherapy for adults with PTSD (Hoskins, Sinnerton, et al, 2021 ) provided information on effective medication for PTSD. And finally non-psychological and non-pharmacological interventions were reviewed and, for instance, yoga, neurofeedback, transcranial magnetic stimulation and acupuncture were considered as promising complementary and alternative approaches (Bisson, Van Gelderen, Roberts, & Lewis, 2020 ).…”

Managing the risk of post‐traumatic stress disorder (PTSD): Best practice for prevention, detection and treatment

“…13 Specific pharmacological interventions are also recommended, albeit to a lesser degree due to lower effect sizes. 14 Since there is evidence for the efficacy of many psychological and pharmacological treatments, the evidence base should be used to guide shared decision-making between patient and clinician. Ideally, intervention should be preceded by detailed assessment, followed by discussion surrounding the evidence, resulting in the co-production of treatment plans that consider patient preference.…”